Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_assertion description "[Furthermore, we have shown that FGF2 can promote the expression of FGF2 and cyclooxygenase-2, and enhance proliferation of endometrial adenocarcinoma cells via the FGFR1 and ERK pathways, thereby establishing a positive feedback loop to regulate neoplastic epithelial cell function in endometrial adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_assertion evidence source_evidence_literature NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_assertion SIO_000772 17478553 NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_assertion wasDerivedFrom befree-20140225 NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_assertion wasGeneratedBy ECO_0000203 NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.
- befree-20140225 importedOn "2014-02-25" NP928424.RAe414Vr3V-fY849O0CC-dMJO9Tr2wM338MsBrQcT68Zs130_provenance.